[HTML][HTML] Biomolecular markers of recurrent implantation failure—A review

AE Mrozikiewicz, M Ożarowski… - International Journal of …, 2021 - mdpi.com
Currently, infertility affects 8–12% of reproductive age couples worldwide, a problem that
also affects women suffering from recurrent implantation failure (RIF). RIF is a complex …

[HTML][HTML] Recurrent pregnancy loss etiology, risk factors, diagnosis, and management. Fresh look into a full box

A Turesheva, G Aimagambetova, T Ukybassova… - Journal of clinical …, 2023 - mdpi.com
Recurrent pregnancy loss is a complex health challenge with no universally accepted
definition. Inconsistency in definitions involves not only the number of spontaneous …

[HTML][HTML] Premature ovarian insufficiency: a review on the role of oxidative stress and the application of antioxidants

YQ Shi, XT Zhu, SN Zhang, YF Ma, YH Han… - Frontiers in …, 2023 - frontiersin.org
Normal levels of reactive oxygen species (ROS) play an important role in regulating follicular
growth, angiogenesis and sex hormone synthesis in ovarian tissue. When the balance …

Gemcitabine cationic polymeric nanoparticles against ovarian cancer: formulation, characterization, and targeted drug delivery

S Bhattacharya, MM Anjum, KK Patel - Drug Delivery, 2022 - Taylor & Francis
This study focused on gemcitabine (GTB) delivery of cationic polymeric nanoparticles to treat
ovarian cancer in order to promote effective localized delivery and drug retention during …

Uterine fluid microRNAs are dysregulated in women with recurrent implantation failure

C von Grothusen, C Frisendahl, V Modhukur… - Human …, 2022 - academic.oup.com
STUDY QUESTION Is the composition of microRNAs (miRNAs) in uterine fluid (UF) of
women with recurrent implantation failure (RIF) different from that of healthy fertile women …

[HTML][HTML] Inhibitors of bacterial extracellular vesicles

J Chen, H Zhang, S Wang, Y Du, B Wei, Q Wu… - Frontiers in …, 2022 - frontiersin.org
Both Gram-positive and Gram-negative bacteria can secrete extracellular vesicles (EVs),
which contain numerous active substances. EVs mediate bacterial interactions with their …

Neo-vascularization-based therapeutic perspectives in advanced ovarian cancer

V Bhardwaj, X Zhang, V Pandey, M Garg - Biochimica et Biophysica Acta …, 2023 - Elsevier
The process of angiogenesis is well described for its potential role in the development of
normal ovaries, and physiological functions as well as in the initiation, progression, and …

[HTML][HTML] Human platelet-rich plasma facilitates angiogenesis to restore impaired uterine environments with Asherman's syndrome for embryo implantation and …

MK Kim, JA Yoon, SY Yoon, M Park, WS Lee, SW Lyu… - Cells, 2022 - mdpi.com
Asherman's syndrome (AS) is caused by intrauterine adhesions and inactive endometrium
from repeated curettage of the uterine endometrium. AS is a major cause of recurrent …

[HTML][HTML] Insights into the immunomodulatory regulation of matrix metalloproteinase at the maternal-fetal interface during early pregnancy and pregnancy-related …

M Jing, X Chen, H Qiu, W He, Y Zhou, D Li… - Frontiers in …, 2023 - frontiersin.org
Trophoblast immune cell interactions are central events in the immune microenvironment at
the maternal-fetal interface. Their abnormalities are potential causes of various pregnancy …

Circular RNA Pvt1 oncogene (CircPVT1) promotes the progression of papillary thyroid carcinoma by activating the Wnt/β-catenin signaling pathway and modulating …

L Zeng, S Yuan, P Zhou, J Gong, X Kong, M Wu - Bioengineered, 2021 - Taylor & Francis
Circular RNAs (circRNAs) have been reported to be involved in the progression of papillary
thyroid carcinoma (PTC). However, the role of circular RNA Pvt1 oncogene (circPVT1) in …